Award-winning partnership proves Vocantas CallAssure effective tool for chronic disease management



    Thrombosis unit at The Ottawa Hospital purchases system to reduce
    workload, improve patient care, minimize wait times in emergency rooms

    OTTAWA, April 28 /CNW Telbec/ - Vocantas Inc., a developer of automated
telephone outreach solutions, today announced the sale of its CallAssure
solution to The Ottawa Hospital to manage patients in its Thrombosis Program.
    This comes as a new study published in the Canadian Medical Association
Journal shows that CallAssure was effective in helping The Ottawa Hospital
keep thrombosis patients in the proper dosing range an impressive 80 percent
of the time. In addition the clinic experienced a 33 percent reduction in
staff workload. The purchase and full-time deployment of CallAssure may
ultimately allow The Ottawa Hospital Thrombosis Program to efficiently and
effectively manage the blood thinners of more than 10,000 patients in the
region in this manner.
    Thrombosis is a chronic disease characterized by the development of clots
in blood vessels. Patients must maintain an optimal level of a blood-thinning
agent in their bodies, and so require regular blood testing that can indicate
the need for possible and sometimes frequent, adjustments to their dosage of
blood thinner. The very high level of human interaction required to schedule
testing, and reschedule when patients fail to show up, and then to communicate
the test results and any dosage change has meant that optimal disease
management is often beyond what healthcare systems can afford. Patients
without family doctors must often resort to hospital emergency rooms for their
testing, and then they must wait there, often for hours, for the test results
and dosage details.
    Dr. Marc Rodger, Head of the Thrombosis Program at The Ottawa Hospital,
recognized the benefits derived by implementing the system. "CallAssure has
the potential to positively impact both the patient and the system," said Dr.
Rodger, who is also a senior scientist at the Ottawa Hospital Research
Institute and an associate professor of medicine at the University of Ottawa.
"By enabling us to effectively and efficiently monitor patients remotely, the
number of patients we can safely service is increased, improving the quality
of care we can deliver to them."
    "In addition, our skilled clinical resources can be put to better use by
devoting time to patient care rather than spending unproductive time trying to
reach patients by telephone."
    Working closely with Dr. Marc Rodger and others at The Ottawa Hospital,
Vocantas used CallAssure to better manage chronic diseases, by alerting
patients of upcoming test requirements and any changes to their care plan. By
successfully integrating with dosing technology, CallAssure informed patients
immediately when their medication dosage is adjusted.
    Patients who were part of the CallAssure technology trial at The Ottawa
Hospital were enthusiastic about their experience. "The automated system has
made my care more efficient," said Rick Dokomos of Ottawa. "Traveling for
three months of the year, as I do, I can rely on the system to contact me
about dosing and testing and not have to worry about it - now I can enjoy
life."
    Other patients have credited the system with keeping them from harm by
ensuring their dosing regimen remains on track. "This is my lifeline," said
Dianna Siteman, also of Ottawa. "If I don't take my medication properly, I can
get into a lot of problems. I think it's great and it's going to help a lot of
people."
    The challenge of effectively managing chronic disease has been
highlighted both here in Canada and in the United States. The 2007 National
Physician Survey reported that 80 percent of doctors in Canada said that
patients with chronic diseases place the biggest demand on their time. In its
2008 report, the Ontario Health Quality Council reported that nearly 8,000
lives could be saved if the province better monitored and treated patients
with chronic conditions such as diabetes and heart disease. Meanwhile, south
of the border, the Centers for Disease Control and Prevention report that
chronic diseases are the leading causes of death and disability, accounting
for 70 percent of all deaths in the U.S., which is 1.7 million each year.
    These compelling challenges are behind the application of CallAssure to
help manage chronic diseases. CallAssure was first developed and evaluated in
collaboration with Dr. Alan Forster, an internal medicine specialist at The
Ottawa Hospital, a scientist at the Ottawa Hospital Research Institute and an
associate professor of medicine at the University of Ottawa. He is a leading
expert in patient safety and he has worked with Vocantas for four years to
develop and evaluate CallAssure, an automated patient survey system that uses
speech-enabled computer telephony to enable clinics and hospitals to more
easily monitor patients to improve care, reduce workload and minimize wait
times in local emergency rooms. For this collaborative work, Vocantas received
the 2009 Technology Commercialization Partnership award presented by Ottawa's
Lead Economic Development Corporation (OCRI).
    "The Ottawa Hospital has decided to deploy CallAssure as part of an
ongoing care plan, a routine part of the patient's care," said Gary T. Hannah,
founder and president of Vocantas. "Since the evaluation of the technology,
both patients and clinicians have come to depend on the system to keep the
care plan on track and to free up skilled people who can now devote their
attention to patient care, where it belongs.
    "In the process, adoption of a technology solution to manage chronic
diseases has the potential to impact grand-scale issues like emergency room
waiting times and enrolment capabilities for life-saving programs such as
those run by the thrombosis unit."

    About Vocantas

    Vocantas is a developer of interactive voice response systems (IVRS) that
use advanced computer telephony and speech technology to provide its customers
with cost-effective customer outreach solutions. The company's easy-to-use,
turn-key solutions offer customizable core features and optional enhancements
that integrate seamlessly with existing systems. Its products have particular
application in the healthcare, education, utilities and customer service
environments where they have been proven to increase efficiencies while
minimizing operational costs. For more information, please visit
www.vocantas.com.

    About The Ottawa Hospital and its Thrombosis Program

    The Ottawa Hospital is a multi-campus, academic health sciences centre
serving the 1.2 million residents of Ottawa and Eastern Ontario, both in
English and French. The Ottawa Hospital Research Institute and the University
of Ottawa are important partners in health research and education. The Ottawa
Hospital's Thrombosis Program focuses on management of 1) pulmonary embolism
(clot in the lung) and deep vein thrombosis (clot in the leg) and 2) blood
thinner management. The Program offers safe, efficient and novel management
strategies that permit the delivery of quality cost effective care to the
Champlain LHIN. The Program is active in clinical research and delivers
practice changing knowledge generation. For more information visit
http://www.ottawahospital.on.ca.




For further information:

For further information: Vocantas Marketing Communications, (877)
271-8853 X 545, info@vocantas.com

Organization Profile

VOCANTAS

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890